financetom
Business
financetom
/
Business
/
--Stride Guides For Q2 Revenue of $560-$580 Million, vs CIQ Analyst Consensus of $535 Million: Sees FY 2025 Revenue at $2.225-$2.3 Billion, vs Consensus of $2.2 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Stride Guides For Q2 Revenue of $560-$580 Million, vs CIQ Analyst Consensus of $535 Million: Sees FY 2025 Revenue at $2.225-$2.3 Billion, vs Consensus of $2.2 Billion
Oct 22, 2024 1:51 PM

04:17 PM EDT, 10/22/2024 (MT Newswires) --

Price: 74.97, Change: +10.48, Percent Change: +16.25

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
T. Rowe Price Group August Assets Under Management Rise Month Over Month
T. Rowe Price Group August Assets Under Management Rise Month Over Month
Sep 11, 2025
09:13 AM EDT, 09/11/2025 (MT Newswires) -- T. Rowe Price ( TROW ) reported preliminary assets under management Thursday of $1.729 trillion as of Aug 31, up from $1.703 trillion in the previous month. The company said its equity assets rose to $867 billion at the end of August from $859 billion as of July 31, and multi-assets increased to...
Sector Update: Consumer Stocks Advance Premarket Thursday
Sector Update: Consumer Stocks Advance Premarket Thursday
Sep 11, 2025
09:14 AM EDT, 09/11/2025 (MT Newswires) -- Consumer stocks were advancing premarket Thursday, with the Consumer Discretionary Select Sector SPDR Fund ( XLY ) up 0.3% and the Consumer Staples Select Sector SPDR Fund ( XLP ) 0.1% higher. Alibaba Group ( BABA ) shares were up 3.1% after the company said it priced a $3.2 billion offering of zero...
Protagonist Says Johnson & Johnson Submits Application to EMA for Plaque Psoriasis Treatment
Protagonist Says Johnson & Johnson Submits Application to EMA for Plaque Psoriasis Treatment
Sep 11, 2025
09:12 AM EDT, 09/11/2025 (MT Newswires) -- Protagonist Therapeutics ( PTGX ) said Thursday that its partner, Johnson & Johnson ( JNJ ) , has submitted an application to the European Medicines Agency seeking approval of icotrokinra to treat moderate-to-severe plaque psoriasis in adults and adolescents above 12 years of age. The investigational oral tablet selectively blocks the IL-23 receptor,...
XPEL Acquires Assets of Chinese Distributor
XPEL Acquires Assets of Chinese Distributor
Sep 11, 2025
09:09 AM EDT, 09/11/2025 (MT Newswires) -- XPEL ( XPEL ) said Thursday it has acquired the assets of its exclusive distributor in China aftermarket. Financial terms of the transaction were not disclosed. The transaction structure will result in XPEL ( XPEL ) owning a 76% interest in the Chinese entity conducting business in China. The company said the purchase...
Copyright 2023-2026 - www.financetom.com All Rights Reserved